Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE: 603538)
Health Care · Pharmaceuticals · CN
CN¥28.45
-0.49% today · +82.5% 1Y
Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE: 603538) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.44B and employs 2,370 people.
Over the last twelve months the share price has gained 82.5%, trading between 13.55 and 50.28.
Tweenvest scores Ningbo Menovo Pharmaceutical Co., Ltd. across four factors: quality 60/100, value 31/100, growth 78/100, dividend 10/100. Its strongest factor is growth.
603538 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.44B
- Revenue (TTM)
- $248.00M
- P/E
- 76.32
- EPS
- 0.37
- Dividend yield
- 0.39%
- Beta (5Y)
- -0.15
- 52-week high
- CN¥50.28
- 52-week low
- CN¥13.55
- Avg volume (3M)
- —
- Shares outstanding
- 339.93M
- Employees
- 2,370
- Next earnings
- —
About Ningbo Menovo Pharmaceutical Co., Ltd.
Ningbo Menovo Pharmaceutical Co., Ltd. operates across the full spectrum of pharmaceutical activities, encompassing the research, development, production, and distribution of medicinal products. Their extensive product line features Active Pharmaceutical Ingredients (APIs), intermediate chemicals, and finished drug formulations. These offerings are designed to address a wide range of therapeutic areas, including cardiovascular, central nervous system, respiratory, oncological, anti-infective, digestive, and geriatric disorders, as well as antiviral treatments. The company commenced operations in 2004 and maintains its principal place of business in Ningbo, China.
- ISIN
- CNE100002Y25
- Founded
- 2004
- Listed since
- Apr 10, 2017
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GH Research PLCNasdaqGM: GHRS | $1.45B | $20.42 | -3.27% |
| Green Thumb Industries Inc.CNSX: GTII | $1.45B | CA$9.45 | +1.39% |
| Pacira BioSciences, Inc.NasdaqGS: PCRX | $1.45B | $36.34 | +0.08% |
| Marksans Pharma LimitedNSEI: MARKSANS | $1.45B | Rs309.10 | -5.07% |
| ST Pharm Co.,Ltd.KOSDAQ: A237690 | $1.44B | ₩92,900.00 | -0.43% |
| Omeros CorporationNasdaqGM: OMER | $1.44B | $19.89 | +0.30% |
| Nippon Shinyaku Co., Ltd.TSE: 4516 | $1.44B | ¥3,372.00 | +0.12% |
| Xiamen Kingdomway Group CompanySZSE: 002626 | $1.43B | CN¥15.89 | -1.49% |
Figures last refreshed Oct 11, 2026.